Cem Meydan
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Aging top 5%
Papers in
-
- Epigenetics and DNA Methylation 13
- RNA Research and Splicing 6
- Cancer-related gene regulation 6
- Histone Deacetylase Inhibitors Research 4
- Hematology 12
- Acute Myeloid Leukemia Research 11
- Co-authors
- Christopher E. Mason (32 shared papers)Samie R. Jaffrey (1 shared paper)Anya V. Grozhik (1 shared paper)Anthony O. Olarerin-George (1 shared paper)Bastian Linder (1 shared paper)Ari Melnick (24 shared papers)Jonathan Foox (13 shared papers)Daniel Butler (12 shared papers)
- Journals
- Blood (11 papers)Cell Reports (5 papers)Cancer Discovery (4 papers)Cancer Cell (2 papers)iScience (2 papers)
- Partner nations
- United StatesIsraelTürkiye
In The Last Decade
Cem Meydan
53 papers receiving 3.0k citations
Cem Meydan's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 832
- Aging 58
- Molecular Biology 2.2k
- Hematology 298
- Infectious Diseases 281
Countries citing papers authored by Cem Meydan
This map shows the geographic impact of Cem Meydan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Meydan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Meydan more than expected).
Fields of papers citing papers by Cem Meydan
This network shows the impact of papers produced by Cem Meydan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Meydan. The network helps show where Cem Meydan may publish in the future.
Co-authors
The 25 scholars most cited alongside Cem Meydan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome Hit paper breakdown → | 2015 | 1180 |
| 2 | The spatial landscape of lung pathology during COVID-19 progression Hit paper breakdown → | 2021 | 212 |
| 3 | 2020 | 207 | |
| 4 | 2021 | 153 | |
| 5 | 2018 | 122 | |
| 6 | 2015 | 113 | |
| 7 | 2020 | 83 | |
| 8 | 2017 | 71 | |
| 9 | 2020 | 71 | |
| 10 | 2019 | 69 | |
| 11 | 2017 | 62 | |
| 12 | 2017 | 61 | |
| 13 | 2018 | 60 | |
| 14 | 2020 | 59 | |
| 15 | 2020 | 57 | |
| 16 | 2020 | 41 | |
| 17 | 2020 | 36 | |
| 18 | 2014 | 29 | |
| 19 | 2013 | 26 | |
| 20 | 2020 | 24 |
About Cem Meydan
Cem Meydan is a scholar working on Molecular Biology, Hematology, Physiology, Immunology and Cancer Research, having authored 54 papers that have together received 3.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), Acute Myeloid Leukemia Research (11 papers), Spaceflight effects on biology (7 papers), RNA Research and Splicing (6 papers), Telomeres, Telomerase, and Senescence (6 papers), Cancer-related gene regulation (6 papers), Cancer Genomics and Diagnostics (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (832 citations), Aging (58 citations), Molecular Biology (2.2k citations), Hematology (298 citations) and Infectious Diseases (281 citations). Cem Meydan has collaborated with scholars based in United States, Israel and Türkiye. Frequent co-authors include Christopher E. Mason, Samie R. Jaffrey, Anya V. Grozhik, Anthony O. Olarerin-George, Bastian Linder, Ari Melnick, Jonathan Foox, Daniel Butler, Francine E. Garrett-Bakelman and Ebrahim Afshinnekoo. Their work appears in journals such as Blood, Cell Reports, Cancer Discovery, Cancer Cell and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.